Efficacy of vitamin D in augmenting behavioral intervention in children with autism spectrum disorder: a randomized placebo controlled double blinded trial

ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Newly diagnosed patients with autism spectrum disorder
•2.All consecutive children between age 3-8 years attending the Child Psychiatry Clinic, JIPMER hospital, with a diagnosis of Autism Spectrum Disorder as per DSM 5

•1.Patient on vitamin D-based therapy within 6 months prior to screening.
•2.Patients with symptomatic vitamin D deficiency
•3.Patient with a history of allergy or sensitivity to vitamin D or its analogues.
•4.Patients with coexisting diseases, such as, chronic gastrointestinal disease, myocardial infarction, cerebrovascular accident, congestive heart failure, cardiomyopathies, peripheral vascular diseases, malignancies and renal stones.
•5.Patient has received any investigational drug <= 3 months prior to this study.
•6.Patient on any drugs modulating calcium metabolism and homeostasis

发起方

ICMR